# Turtle Health, Inc. — Form D

Turtle Health, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-11. The offering totals $2.8M, of which $2.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-02-11
- Form: D
- Accession: 0001910243-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.7M
- Remaining: $140K
- Investors: 15
- Date of first sale: 2022-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-433233

## Issuer

- Name: Turtle Health, Inc.
- CIK: 0001910243
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 101 ARCH STREET, BOSTON, MA, 02110
- Phone: 2024150021

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Paul Arnold | Director | San Francisco, CA |
| Heather Bell | Director | Boston, MA |
| Amy Zwanziger | Director | Boston, MA |
| Joshua Haselkorn | Executive Officer | Boston, MA |
| Amy Zwanziger | Executive Officer | Boston, MA |

## More

- [CIK 1910243 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1910243&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001910243-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.